BOSTON, Dec. 19, 2013 /PRNewswire-iReach/ -- inviCRO hires Stefan Linehan as Director of Ex Vivo Research & Imaging Services
BOSTON, MA—inviCRO is pleased to announce the hiring of Stefan Linehan, MS, as the Director of Ex Vivo Research & Imaging Services. He will integrate in vivo and ex vivo imaging technologies and help bring 3D autoradiography capabilities to inviCRO's newly opened laboratory.
As the industry expert on cryo-imaging techniques, Linehan developed the Cryo-Imaging Quantitative Tomography (CIQuanT) system, which animates entire carcasses of study animals for tissue structural mapping and size determination. The generated information will give analysts unique perspectives inside animals. inviCRO plans to merge innovative in vivo and ex vivo imaging techniques in order to improve understanding of the drug development process
Jack Hoppin, Ph.D., co-founder and managing partner of inviCRO, stated, "Stefan's appointment is a great addition to our team. Through his efforts, our ex vivo division will provide a bridge between the ex vivo and in vivo preclinical nuclear imaging efforts. This novel approach allows researchers to study the biodistribution of pharmaceuticals on a broad array of temporal and spatial resolutions."
Linehan has fifteen years of experience in the field, holding previous positions at XenoBiotic Laboratories and WIL Research Laboratories, where he set up quantitative whole body autoradiography (QWBA) capabilities and conducted mass balance/tissue distribution studies. He has also worked at Wyeth Pharmaceuticals, where he conducted WBA and other tissue distribution studies. Linehan received his Masters in Clinical Biochemistry from Griffith University in Queensland, Australia and his Bachelors in Biology from Colorado State University in Fort Collins, CO. Linehan is currently the President of the Society for Whole Body Autoradiography (SWBA) and has held multiple Executive Committee Officer positions since 2003.
inviCRO was founded with a mission of improving the value of imaging in drug discovery and development. The company provides a full range of imaging services and software solutions including contract research services, custom data analysis, and software programs for image data management and high-throughput image processing. Their experienced team of more than 25 research scientists possesses unique capabilities in imaging physics, advanced biostatistics, multi-dimensional image processing, software development, as well as an intimate understanding of imaging systems, agents, and animal models. inviCRO has managed and/or processed more than 425 research imaging trials since 2008. Their software products are used in more than 125 laboratories worldwide, including 13 of the top 25 pharmaceutical companies. inviCRO was recently named the 327th fastest growing company in the United States by Inc. Magazine.
Media Contact: Lina Zhong, inviCRO, LLC, 6179042116, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com